Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > I give up

<< Previous

Bullboard Posts

Next >>

Comment by Biobobon Sep 19, 2022 3:37pm

105 Views

Post# 34972000

RE:RE:RE:RE:RE:I give up

Bucknelly is 100% right on that one.. the IR person sounds like an answering machine.. an insult to the kind of discussion large and long term shareholder should have not with IR but with CEO. And yes they delivered nothing that translated and in anything for shareholders. I am deeply disapointed in our last ditch effort to bring this company to another level. It as been a mistake to hire Paul Mme Chairwomen. Unfortunatly it was our last chance at it in my book.

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market